Starting a South African clinical programme.

Who this is for

Sponsors, CROs, research institutions, sites, investigators, laboratories and vendors

Typically instructed by: Clinical operations · study start-up · site contracts and outsourcing · research contracts offices

What tends to go wrong

Where this workstream fails without South African counsel

• Site legal desks at academic hospitals hold positions that international sponsor templates do not accommodate, and the negotiation stalls.
• Insurance requirements collide between sponsor cover, CRO cover and South African statutory expectations.
• The indemnity chain between sponsor, CRO and site turns out to be uncertain when a specific clause is invoked.
• Data-protection wording assumes GDPR alone and misses what POPIA requires.
• Publication rights are left until they matter.

Scope

What JW van Zyl Inc owns in this workstream

Clinical trial agreements

Sponsor-side or CRO-side review and negotiation of sponsor-site, sponsor-institution and tripartite agreements, including budget schedules and payment terms.

Sponsor and CRO agreements

Master services agreements, work orders, transfer of regulatory obligations and change-order mechanics.

Indemnity and insurance

Reconciliation of the sponsor, CRO and site indemnity and insurance positions so that the chain holds when it is tested.

Data and samples

POPIA data-protection addenda for clinical data transfers, and the legal position on sample import, export, storage and future use.

Ethics and regulatory interface

Contract-level alignment with the approved protocol, the ethics committee's conditions and the SAHPRA authorisation, coordinated with the clinical-operations lead.

Publication and IP

Publication rights, review periods, embargoes and the ownership of arising intellectual property.

Laboratory and vendor agreements

Central and local laboratory, imaging, courier, IRT and other specialist vendor arrangements.

Outside this workstream

What the firm does not take on here

• Protocol design and substantive ethics review.
• GCP audit.
• Regulatory-affairs submissions to SAHPRA, which sit with the regulatory team.

How the workstream is instructed

Discovery, scoping, engagement

• Discovery. You identify the study, the sites or institutions involved, the template in use and the activation deadline.
• Scoping. The firm runs a conflicts check against the parties and, for a programme rather than a single agreement, an Initial Matter Assessment at a fixed fee that sets the negotiation plan.
• Engagement. Scope, deliverables, fees and timelines are agreed in writing before the first mark-up goes out.

Timing and fee shapeSingle agreements are engaged as a fixed fee. A multi-site programme is scoped against the activation deadline and engaged as a fixed fee per deliverable or a bounded hourly estimate; a programme that continues beyond activation moves to a monthly retainer.

Illustrative situations from prior professional experience are available on request. Anonymised matters comparable to this work are listed under Experience.

Before you instruct

What helps the firm assess the matter

• The parties to the agreements and any related entities, for the conflicts check.
• The protocol number or study identifier, and the sites or institutions involved.
• The template in use and whether it is the sponsor's, the institution's or a national template.
• The start-up deadline the programme is working to.

Free tool

Before you instruct, work through the checklist

Use the Clinical trial agreement checklist · the terms that hold up study activation.